Delivery Order SPE2DB20D2104-SPE2DB23FR69D
Award Date 1/5/23
Potential Completion Date 1/6/23
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,511.40, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,982.29 for the supply of NARCAN 4 MG NASAL SPRAY 2S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.32 firm fixed-price delivery order is for NARCAN 4 MG NASAL SPRAY 2S, with a performance completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $7,940.14 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023, with a completion date of May 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S over a period ending on April 16, 2024. The contract, valued at $2,213.85, was awarded by the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,559,524,860 units of NARCAN 4 mg nasal spray, a critical medication for the treatment of opioid overdoses. The award, valued at $17,163.42, is under a firm-fixed-price contract type and has a period of performance through January 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen, as a major...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical emergency medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The contract, valued at $2,271.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,114.26 firm fixed price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a performance period through March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for opioid overdose reversal. The contract has a ceiling value of $9,037.88 and an ultimate completion date of May 9, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $1,463.04 firm-fixed-price delivery order has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the Department of Defense (DoD) and Department of...